Peer-Reviewed Journal Articles

Verdikt, R., Thienpont, B. Epigenetic remodelling under hypoxia. Seminars in Cancer Biology, 2024 Jan:98:1-10. doi: 10.1016/j.semcancer.2023.10.005.

Verdikt, R., Armstrong, A. A., Cheng, J., Hwang, Y. S., Clark, A. T., Yang, X., Allard, P, Metabolic memory of Δ9-tetrahydrocannabinol exposure in pluripotent stem cells and primordial germ cells-like cells. eLife, October 2023. doi:10.7554/eLife.88795.1.

Verdikt, R., Bendoumou, M., Bouchat, S., Nestola, L., Pasternak, A., Darcis, G., Avettand-Fenoel, V., Vanhulle, C., Aït-Ammar, A., Santangelo, M., Plant, E., Le Douce, V., Delacourt, N., Cicilionyte, A., Necsoi, C., Corazza, F., Pereira Bittencourt, C., Schwartz, C., Bizet, M., Fuks, F., Sáez-Cirión, A., Rouzioux, C., De Wit, S., Berkhout, B., Gautier, V., Rohr, O., Van Lint, C. Novel role of UHRF1 in the epigenetic repression of the latent HIV-1. EBioMedicine, 2022 May;79:103985.


Verdikt, R., Allard, P. Metabolo-epigenetics: The interplay of metabolism and epigenetics during early germ cells development. Biology of Reproduction Journal, 2021, ioab118:1-9.

 

Verdikt, R., Hernalsteens, O. Van Lint, C. Epigenetic Mechanisms of HIV-1 Persistence. Vaccines, 2021, 9(5)514.

 

Hamann, M.V., Ehmele, P.*, Verdikt, R.*, Bialek-Waldmann, J., Virdi, S., Günther, T., Van Lint, C., Grundhoff, A., Hauber, J., Lange, U.C. Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene. Virus Research, 2020; 293:198260. * equal contribution.

 

Verdikt, R*., Lange U.*, Aït-Ammar, A. Van Lint, C. Epigenetic crosstalk in chronic infection with HIV-1.  Seminars in Immunopathology, 2020; 42:2,187-200. * equal contribution.

 

Ait Ammar A., Kula-Pacurar A., Darcis G., Verdikt R., De Wit S., Gautier V., Mallon P., Marcello A., Rohr O., Van Lint C. Current status of LRAs facing the heterogeneity of HIV-1 cellular and tissue reservoirs. Front. Microbiol., 2019, 10:3060, 1-23.

 

Verdikt, R., Darcis, G., Aït-Ammar, A., Van Lint, C. Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence. Current Opinions in Virology, 2019 Sep 7;38:63-69.

The graphical abstract of this review was selected as a cover for the special issue “Engineering for Viral Resistance”.

 

Kula A., Delacourt N., Bouchat S., Darcis G., Avettand-Fenoël V., Verdikt R., Corazza F., Necsoi C., Vanhulle C., Bendoumou M., Burny A., De Wit S., Rouzioux C., Rohr O. & Van Lint, C. Heterogeneous HIV-1 reactivation patterns of disulfiram and combined disulfiram+romidepsin treatments. Journal of Acquired Immune Deficiency Syndromes, 2019 Apr 15;80(5):605-613.

 

Le Douce, V., Forouzanfard, F., Eilebrecht, S., Van Driessche, B., Ait-Ammar, A., Verdikt, R., Kurashige, Y., Marban, C., Gautier, V., Candolfi, E., Benecke, A., Van Lint, C., Rohr, O., & Schwartz, C. HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1. Scientific Reports, 2016, 6, 4920. doi:10.1038/srep34920.